VINCOV-19

Description

GS PAPER III: Science and Technology- developments and their applications and effects in everyday life.

Context: The CSIR- Centre for Cellular and Molecular Biology has developed, possibly the first specific drug for COVID-19 treatment, which contain therapeutic antibodies.

More about news:

The Drug Controller General of India (DGCI) has given its approval for human trials, Phase-I and Phase-II for the VINCOV-19 and expected to be tried next week in Delhi and Rajasthan.
Developed by the CCMB, University of Hyderabad and Vins Bioproduct ltd combine, the VINCOV-19 is a collection of antibodies from Horses after they got injected inactivated Corona virus.
It may take 3-4 weeks for getting approval for emergency use.
VINCOV may be the first specific drug for COVID treatment and it works best when given on early stage of infection.

http://newsonair.com/News?title=CSIR--CCMB-develops-possibly-1st-specific-drug-for-COVID-19-treatment&id=415867